Medical illustration showing the lower esophagus and the change in lining associated with Barrett's esophagus.

Barrett's esophagus is a condition in which the normal lining of the lower esophagus changes into a type of tissue more like the lining of the intestine. It is most often associated with long-standing gastroesophageal reflux disease (GERD). Barrett's esophagus is important because it increases the risk of esophageal adenocarcinoma, but most people with Barrett's esophagus do not develop cancer.

Barrett's esophagus itself usually does not cause symptoms. People often have symptoms of GERD, such as heartburn or regurgitation, but symptoms alone cannot confirm Barrett's. Diagnosis generally requires an upper endoscopy and tissue samples (biopsies). The biopsy report also helps determine whether dysplasia—precancerous cell changes—is present.

Care depends on the biopsy findings. Some people need reflux management and scheduled endoscopic surveillance; others with confirmed dysplasia may be offered endoscopic treatment. Current guidance emphasises high-quality endoscopy, careful biopsy sampling and expert confirmation of dysplasia.

Barrett's Esophagus: Quick Overview

What Is Barrett's Esophagus?

The esophagus is the muscular tube that carries food from the mouth to the stomach. Its normal inner surface is lined by squamous cells. In Barrett's esophagus, a section of the lower esophageal lining changes to columnar cells with intestinal-type features, a process called intestinal metaplasia.

This change is thought to be an adaptation to chronic injury from reflux in susceptible people. Barrett's is considered a precancerous condition because some cases can progress through stages of dysplasia and, less commonly, to esophageal adenocarcinoma. It is not the same as having cancer.

Doctors describe the length of the affected segment and whether dysplasia is present. These details matter because the risk of progression and recommended follow-up are not identical for every person.

Barrett's Esophagus Symptoms

Does Barrett's Esophagus Cause Symptoms?

Barrett's esophagus itself generally does not produce a distinct symptom pattern. It is often discovered during an endoscopy performed because of chronic reflux symptoms or another clinical reason. A person cannot tell from heartburn alone whether Barrett's tissue has developed.

Symptoms That May Come From GERD

• Heartburn: A burning feeling behind the breastbone, often after meals or when lying down.
• Regurgitation: Sour or bitter fluid, or food, coming back up toward the throat or mouth.
• Chest discomfort: Reflux can cause chest discomfort, but chest pain must not automatically be assumed to be reflux.
• Chronic cough or hoarseness: These can occur in some people with reflux but have many other possible causes.
• Difficulty swallowing: Dysphagia can have several causes and needs medical assessment, particularly if it is new or worsening.

What Causes Barrett's Esophagus?

The exact biological process is not fully understood. Chronic reflux is the strongest recognised association. Repeated exposure to stomach acid and other gastric contents may injure the lower esophageal lining; in some people, the tissue changes to an intestinal-type lining.

Not everyone with long-term GERD develops Barrett's, and Barrett's can occasionally be identified in people who do not report typical reflux symptoms. It is not caused by an infection that spreads between people.

Risk Factors for Barrett's Esophagus

• Chronic GERD: Frequent, long-standing reflux is the most established clinical risk factor.
• Age: Barrett's is more commonly diagnosed in middle-aged and older adults.
• Sex: It is diagnosed more often in men than women.
• Central obesity: Abdominal fat is associated with a higher risk of reflux and Barrett's.
• Smoking history: Tobacco use is associated with Barrett's and esophageal adenocarcinoma risk.
• Family history: A close family history of Barrett's esophagus or esophageal adenocarcinoma may increase concern.
• Other demographic factors: Risk patterns vary across populations; a clinician considers the full history rather than one factor alone.

Risk factors do not diagnose Barrett's. Screening decisions are individualised, taking account of reflux duration, age, sex, family history and other clinical features.

How Is Barrett's Esophagus Diagnosed?

The standard diagnostic approach is an upper gastrointestinal endoscopy (also called esophagogastroduodenoscopy or EGD) with biopsies. The endoscopist examines the esophagus, identifies any suspicious segment and collects tissue samples for a pathologist to assess.

1. Upper Endoscopy

A thin flexible camera is passed through the mouth to examine the esophagus, stomach and upper small intestine. Sedation is commonly offered, depending on local practice and the patient's needs. The clinician documents the appearance and length of any suspected Barrett's segment and looks for visible abnormalities.

2. Biopsy and Pathology

Small tissue samples are taken through the endoscope. A pathologist checks whether intestinal metaplasia is present and whether dysplasia or cancer is identified. Sampling several areas matters because abnormal changes may be patchy and not visible to the naked eye.

3. High-Quality Inspection and Structured Sampling

Updated AGA guidance published in 2025 recommends high-definition white-light endoscopy combined with chromoendoscopy during surveillance, along with a structured biopsy protocol. Any visible lesion needs careful targeted assessment. The purpose is to improve detection and reduce the chance of missing important tissue changes.

4. Expert Review of Dysplasia

Inflammation and tissue repair can sometimes resemble dysplasia. If a biopsy is reported as indefinite for dysplasia or low-grade dysplasia, expert gastrointestinal pathology review is important. The diagnosis may be confirmed or revised after review and, when appropriate, repeat endoscopy with optimised reflux control.

5. Screening: Who May Need to Discuss It?

Screening is not recommended for every person with occasional heartburn. A clinician may discuss screening when reflux has been frequent for years and additional risk factors are present. The decision depends on the person's age, medical history, family history, overall health and local guidelines.

Understanding Biopsy Results: No Dysplasia, Indefinite, Low-Grade and High-Grade

Dysplasia is not the same as invasive cancer. The biopsy category must be interpreted by the treating specialist alongside endoscopy findings and expert pathology review.

Barrett's Esophagus and Cancer Risk

Barrett's esophagus is associated with an increased risk of esophageal adenocarcinoma, but the absolute risk for an individual varies. Most people with nondysplastic Barrett's do not develop cancer. Risk is higher when dysplasia is confirmed, particularly high-grade dysplasia, and may also be influenced by segment length and other clinical factors.

The reason for surveillance is to identify dysplasia or early cancer at a stage when endoscopic treatment may be possible. Surveillance does not eliminate risk, and follow-up should be based on the pathology result and a high-quality endoscopic assessment.

Barrett's Esophagus Surveillance: Why and How Often?

Surveillance means repeating endoscopy at planned intervals to look for dysplasia or early cancer. The interval depends on the biopsy result, length of the Barrett's segment, quality of the previous examination, age, other health conditions and the patient's preferences.

Important: These are guideline-level examples, not a personal appointment schedule. The 2025 AGA guideline emphasises shared decision-making, high-quality endoscopy and structured biopsies. Your gastroenterologist should tell you the next date based on your actual report.

Barrett's Esophagus Treatment Options

Treatment is based on whether dysplasia is present. The plan may include acid-suppressing medicine, lifestyle measures, surveillance endoscopy or endoscopic treatment. Surgery is not routinely used just to remove nondysplastic Barrett's tissue.

1. Proton Pump Inhibitors (PPIs)

PPIs reduce stomach acid and are commonly used to manage GERD in people with Barrett's esophagus. The 2025 AGA surveillance guideline conditionally suggests daily PPI therapy compared with no PPI therapy to reduce neoplastic progression. The right medicine and dose depend on the person's symptoms, endoscopy findings, other medicines and medical history.

Do not start long-term acid-suppressing treatment or change a prescribed dose without discussing benefits and potential risks with a clinician. Persistent symptoms despite treatment should be reviewed rather than self-treated indefinitely.

2. Endoscopic Eradication Therapy (EET)

For selected people with confirmed dysplasia or early neoplasia, treatment can be performed through an endoscope without removing the esophagus. EET may include removing a visible abnormal area and treating remaining Barrett's tissue with an ablation technique.

3. Endoscopic Mucosal Resection (EMR)

EMR removes a visible abnormal area from the esophageal lining. The removed tissue is examined to determine the depth and nature of the abnormality. It may be followed by ablation of remaining Barrett's tissue when appropriate.

4. Radiofrequency Ablation (RFA) and Other Ablation Methods

Ablation uses controlled energy to destroy abnormal Barrett's lining so it can heal with a different lining. Radiofrequency ablation is a commonly used method. The choice of technique depends on lesion characteristics, expertise and the patient's clinical situation.

5. Who Usually Needs Endoscopic Treatment?

The 2024 AGA endoscopic eradication guideline recommends EET for Barrett's with high-grade dysplasia and suggests it for confirmed low-grade dysplasia after shared decision-making. It suggests against routine EET for nondysplastic Barrett's. The balance of benefit and risk differs by biopsy grade.

6. Surgery

Antireflux surgery may be considered for selected patients with significant GERD for standard reflux-related reasons, but it is not recommended solely as a cancer-prevention substitute for surveillance or indicated endoscopic treatment. Esophagectomy is generally reserved for selected cancers or situations that cannot be managed endoscopically, not routine nondysplastic Barrett's.

Possible Risks of Endoscopic Treatment

Endoscopic eradication therapy can be effective for appropriately selected dysplastic Barrett's, but it is not risk-free. Potential complications include chest discomfort, bleeding, narrowing (stricture) of the esophagus, ulceration and, rarely, perforation. More than one treatment session may be required, and surveillance continues after successful eradication because Barrett's-related changes can recur.

Before treatment, ask the specialist about expected number of sessions, likely benefits, possible complications, reflux control, recovery and the follow-up schedule.

Daily Habits That May Help Manage Reflux

• Consider raising the head of the bed if you have night-time reflux; extra pillows alone may not provide the same effect as elevating the bed head.
• Eat portions that feel comfortable and avoid meals that reliably trigger symptoms.
• Limit alcohol if it worsens reflux or affects your health; avoid tobacco.
• Take prescribed reflux medicines exactly as directed and discuss persistent symptoms with your clinician.
• Do not rely on diet, supplements or home remedies to reverse Barrett's tissue or replace surveillance.

Can Barrett's Esophagus Be Prevented?

There is no guaranteed way to prevent Barrett's esophagus. Managing chronic reflux, maintaining a healthy weight where appropriate, avoiding tobacco and seeking assessment for persistent GERD may help reduce risk or identify complications earlier. These measures do not guarantee that Barrett's will not develop and do not replace endoscopic surveillance once it has been diagnosed.

When Should You See a Doctor?

Discuss recurrent or persistent reflux with a healthcare professional, especially if symptoms occur frequently over years or you have additional risk factors. If Barrett's has already been diagnosed, keep the surveillance appointments recommended by your gastroenterologist and ask for a clear explanation of your biopsy grade.

Frequently Asked Questions About Barrett's Esophagus

Showing 8 of 8 questions

No matching questions found. Try another search term.

Trusted Medical Sources and Further Reading

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Barrett's Esophagus — overview, symptoms, diagnosis and treatment.
• NIDDK: Symptoms and Causes — reflux symptoms, risk context and when to seek medical advice.
• NIDDK: Diagnosis — endoscopy, biopsy and surveillance.
• American Gastroenterological Association (AGA): 2025 Surveillance Guideline — updated surveillance, imaging, biopsy and PPI recommendations.
• AGA: Endoscopic Eradication Therapy Guideline (2024) — treatment recommendations for low- and high-grade dysplasia.
• American College of Gastroenterology: Updated Barrett's Esophagus Guideline — diagnosis, risk stratification and surveillance intervals.

Conclusion: Understand Your Biopsy Result and Keep the Right Follow-Up

Barrett's esophagus is a change in the lower esophageal lining commonly associated with long-standing GERD. It raises the risk of esophageal adenocarcinoma, but most people with Barrett's do not develop cancer. The most important details are the confirmed biopsy result, whether dysplasia is present and the length of the affected segment.

Reflux management, tobacco cessation, healthy weight where appropriate and guideline-based surveillance help support long-term care. If dysplasia is confirmed, specialist review and shared decision-making can guide whether endoscopic treatment or close surveillance is most suitable. Seek prompt medical attention for swallowing difficulty, bleeding, persistent vomiting or unexplained weight loss.

Medical disclaimer: This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Barrett's esophagus diagnosis, cancer-risk assessment, medication decisions and endoscopy intervals must be individualised by a qualified gastroenterology team using the actual endoscopy and pathology reports. Do not start, stop or change prescription medicines based on this article. Seek urgent care for vomiting blood, black stools, progressive swallowing difficulty, unexplained weight loss or severe chest pain.